These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27321644)

  • 1. Serial Morphological and Functional Assessment of the Paclitaxel-coated Balloon for de Novo Lesions.
    Ann SH; Her AY; Singh GB; Okamura T; Koo BK; Shin ES
    Rev Esp Cardiol (Engl Ed); 2016 Nov; 69(11):1026-1032. PubMed ID: 27321644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque modification and stabilization after paclitaxel-coated balloon treatment for de novo coronary lesions.
    Her AY; Shin ES; Chung JH; Kim YH; Garg S; Lee JM; Doh JH; Nam CW; Koo BK
    Heart Vessels; 2019 Jul; 34(7):1113-1121. PubMed ID: 30701291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve.
    Agostoni P; Belkacemi A; Voskuil M; Nathoe HM; Doevendans PA; Stella PR
    JACC Cardiovasc Interv; 2013 Jun; 6(6):569-76. PubMed ID: 23683736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Shin ES; Ann SH; Balbir Singh G; Lim KH; Kleber FX; Koo BK
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):193-200. PubMed ID: 26423017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial Morphological Changes of Side-Branch Ostium after Paclitaxel-Coated Balloon Treatment of De Novo Coronary Lesions of Main Vessels.
    Her AY; Ann SH; Singh GB; Kim YH; Okamura T; Garg S; Koo BK; Shin ES
    Yonsei Med J; 2016 May; 57(3):606-13. PubMed ID: 26996558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instantaneous wave-free ratio-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Chung JH; Shin ES; Her AY; Lee JM; Doh JH; Nam CW; Koo BK
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):179-185. PubMed ID: 31598811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions.
    Her AY; Ann SH; Singh GB; Kim YH; Yoo SY; Garg S; Koo BK; Shin ES
    Yonsei Med J; 2016 Mar; 57(2):337-41. PubMed ID: 26847284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
    Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
    Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-coated balloon treatment for functionally nonsignificant residual coronary lesions after balloon angioplasty.
    Her AY; Shin ES; Lee JM; Garg S; Doh JH; Nam CW; Koo BK
    Int J Cardiovasc Imaging; 2018 Sep; 34(9):1339-1347. PubMed ID: 29696453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical and Physiological Changes after Paclitaxel-Coated Balloon for Atherosclerotic De Novo Coronary Lesions: Serial IVUS-VH and FFR Study.
    Ann SH; Balbir Singh G; Lim KH; Koo BK; Shin ES
    PLoS One; 2016; 11(1):e0147057. PubMed ID: 26824602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of fractional flow reserve and angiographic characteristics after balloon angioplasty in de novo coronary lesions.
    Chung JH; Lee KE; Her AY; Lee JM; Doh JH; Nam CW; Koo BK; Shin ES
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):1945-1954. PubMed ID: 31214851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease.
    Wöhrle J; Birkemeyer R; Markovic S; Nguyen TV; Sinha A; Miljak T; Spiess J; Rottbauer W; Rittger H
    Heart; 2011 Aug; 97(16):1338-42. PubMed ID: 21617163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.
    Nijhoff F; Stella PR; Troost MS; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Agostoni P
    Clin Res Cardiol; 2016 May; 105(5):401-11. PubMed ID: 26541146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
    Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty.
    Tada T; Kadota K; Hosogi S; Miyake K; Amano H; Nakamura M; Izawa Y; Kubo S; Ichinohe T; Hyoudou Y; Eguchi H; Hayakawa Y; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Tanaka H; Fuku Y; Kato H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):307-15. PubMed ID: 24042176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results.
    López Mínguez JR; Nogales Asensio JM; Doncel Vecino LJ; Sandoval J; Romany S; Martínez Romero P; Fernández Díaz JA; Fernández Portales J; González Fernández R; Martínez Cáceres G; Merchán Herrera A; Alfonso Manterola F;
    EuroIntervention; 2014 May; 10(1):50-7. PubMed ID: 24832638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of late lumen enlargement after drug-coated balloon angioplasty for de novo coronary lesions.
    Yamamoto M; Hara H; Kubota S; Hiroi Y
    EuroIntervention; 2024 May; 20(9):602-612. PubMed ID: 38726721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty.
    Kleber FX; Schulz A; Waliszewski M; Hauschild T; Böhm M; Dietz U; Cremers B; Scheller B; Clever YP
    Clin Res Cardiol; 2015 Mar; 104(3):217-25. PubMed ID: 25349065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic efficacy of paclitaxel-coated balloon for de novo coronary lesions with diameters larger than 2.8 mm].
    Yu X; Ji FS; Xu F; Zhang WD; Wang XY; Lu D; Xu T
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):32-38. PubMed ID: 29374935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.